Canadian Biotech To Apply Biocompatible Coating To Drug-Eluting Stents
This article was originally published in The Pink Sheet Daily
Executive Summary
MIV Therapeutics’ letter of intent to acquire Indian stent manufacturer heralds biocompatible coating development for drug-eluting stents. Sahajanand Medical Technologies is “the largest privately held producer of coronary drug-eluting stents outside of North America,” MIVT says.